跳至主要内容
临床试验/JPRN-jRCT2080221344
JPRN-jRCT2080221344未知3 期

Remission Phase Study with MD-0901 -Phase 3 Clinical Trial in Patients with Ulcerative Colitis in Remission Phase

MOCHIDA PHARMACEUTICAL CO., LTD.0 个研究点目标入组 190 人开始时间: 2011年1月6日最近更新:

试验速览

阶段
3 期
入组人数
190

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Subjects who are diagnosed as ulcerative colitis
  • 2)Subjects who are in remission (defined as the Ulcerative Colitis Disease Activity Index (UC-DAI) score of 2 or less and a rectal bleeding score of 0)
  • 3)Outpatients

排除标准

  • 1)Subjects with a history of colectomy (except appendectomy)
  • 2)Subjects with moderate/severe renal or liver impairment
  • 3)Subjects with serious blood disorder, respiratory disorder, digestive disorder, cardiovascular disorder, psychiatric disorder, abnormal electrolyte metabolism disorder or hypersensitivity as complication
  • 4)Subjects with malignant tumor as complication

研究者

相似试验